RXRX · Forms 3, 4, 5
Insider trades at RECURSION PHARMACEUTICALS, INC.
2 insiders sold $367K of RECURSION PHARMACEUTICALS, INC. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for RECURSION PHARMACEUTICALS, INC. (RXRX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Blake Borgeson | Director | Sell | 50,000 | $4.84 | $242K | Form 4 | |
| Robert Hershberg | Director | Option exercise | 25,000 | $2.22 | $56K | Form 4 | |
| Robert Hershberg | Director | Sell | 25,000 | $5.00 | $125K | Form 4 | |
| Zavain Dar | Director | Award | 4,607 | Form 4 | |||
| Dean Y Li | Director | Award | 3,378 | Form 4 | |||
| Ben R Taylor | Chief Financial Officer | Tax withholding | 5,396 | $3.41 | $18K | Form 4 | |
| Najat Khan | CEO and President | Sell | 22,408 | $3.52 | $79K | Form 4 | |
| Blake Borgeson | Director | Sell | 30,000 | $3.34 | $100K | Form 4 | |
| Najat Khan | CEO and President | Tax withholding | 80,498 | $3.16 | $254K | Form 4 | |
| David Hallett | Chief Scientific Officer | Tax withholding | 26,657 | $3.16 | $84K | Form 4 | |
| Ben R Taylor | Chief Financial Officer | Tax withholding | 25,018 | $3.16 | $79K | Form 4 | |
| Blake Borgeson | Director | Sell | 30,000 | $3.25 | $98K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.